Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies.
Int J Rheum Dis
; 20(5): 589-596, 2017 May.
Article
in En
| MEDLINE
| ID: mdl-28544533
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Spondylitis, Ankylosing
/
Antirheumatic Agents
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
Aspects:
Patient_preference
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
/
Asia
/
Europa
Language:
En
Journal:
Int J Rheum Dis
Journal subject:
REUMATOLOGIA
Year:
2017
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Reino Unido